1. Background
2. Objectives
3. Methods
4. Results
4.1. Epithelial Malignant Tumors
| Type of Lesion | Frequency | Age Group | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 - 19 | 20 - 29 | 30 - 39 | 40 - 49 | 50 - 59 | 60 - 69 | 70 - 79 | 80 - 89 | 90 - 99 | |||
| Malignant | 519 (100) | 5 (1.2) | 26 (4.8) | 35 (6.5) | 77 (15.4) | 110 (21.8) | 144 (28.9) | 89 (17.8) | 18 (3.5) | 1 (0.1) | 505 (100) |
| SCC | 445 (86.2) | 3 (0.7) | 23 (5.3) | 30 (7) | 69 (15.7) | 93 (21.5) | 129 (30) | 71 (16.4) | 14 (3.2) | 1 (0.2) | 433 (86.3) |
| Verrucous carcinoma | 57 (10.6) | 0 | 1 (1.8) | 3 (5.5) | 3 (5.5) | 15 (27.3) | 12 (21.8) | 17 (30.9) | 4 (7.3) | 0 | 55 (11) |
| Basal cell carcinoma | 7 (1.3) | 0 | 0 | 2 (28.6) | 2 (28.6) | 1 (14.3) | 2 (28.3) | 0 | 0 | 0 | 7 (1.4) |
| Spindle cell carcinoma | 3 (0.6) | 2 (66.7) | 0 | 0 | 1 (33.3) | 0 | 0 | 0 | 0 | 0 | 3 (0.5) |
| Clear cell carcinoma | 4 (0.7) | 0 | 0 | 0 | 2 (50) | 0 | 1 (25) | 1 (25) | 0 | 0 | 4 (0.8) |
| Melanoma | 3 (0.6) | 0 | 2 (3.6) | 0 | 0 | 1 (14.3) | 0 | 0 | 0 | 0 | 3 (0.4) |
| Premalignant | 547 (100) | 17 (3.3) | 64 (12.3) | 104 (20) | 120 (23.1) | 112 (21.5) | 62 (11.9) | 33 (6.3) | 6 (1.2) | 2 (0.4) | 520 (100) |
| Lichen planus | 408 (74.6) | 17 (4.3) | 55 (14.1) | 92 (23.5) | 97 (24.9) | 76 (19.4) | 38 (9.7) | 13 (3.3) | 2 (0.5) | 1 (0.3) | 391 (75.1) |
| Leukoplakia | 115 (21) | 0 | 7 (6.5) | 11 (10.3) | 15 (14) | 33 (30.9) | 19 (17.8) | 18 (16.8) | 4 (3.7) | 0 | 107 (20.5) |
| Epithelial dysplasia | 22 (4) | 0 | 2 (10) | 1 (5) | 8 (40) | 3 (15) | 5 (25) | 0 | 0 | 1 (5) | 20 (3.8) |
| Erytroplakia | 2 (0.4) | 0 | 0 | 0 | 0 | 0 | 0 | 2 (100) | 0 | 0 | 2 (0.3) |
aValues are expressed as No. (%).
bIn 41 cases, age of patients was not recorded in the patient’s record.
| Gender | Type of lesion | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Malignant | Premalignant | |||||||||||
| SCC | V.C | BCC | Spindle. Cell. Ca | Clear. Cell. Ca | Melanoma | Total | Lichen Planus | Leukoplakia | Epithelial Dysplasia | Erytroplakia | Total | |
| Female | 216 (48.9) | 24 (42.11) | 5 (71) | 1 (33) | 1 (25) | 1 (33) | 248 (48) | 222 (55.1) | 47 (41.6) | 15 (71.4) | 0 | 284 (52.7) |
| Male | 227 (51.1) | 33 (57.9) | 2 (29) | 2 (67) | 3 (75) | 2 (67) | 269 (52) | 180 (44.9) | 66 (58.4) | 6 (28.6) | 2 (100) | 254 (47.3) |
| Total | 443 (100) | 57 (100) | 7 (100) | 3 (100) | 4 (100) | 3 (100) | 517 (100) | 402 (100) | 113 (100) | 21 (100) | 2 (100) | 538 (100) |
| P value | 0.336 | 0.009 | ||||||||||
aValues are expressed as No. (%).
bIn 11 cases, gender of patients was not recorded in the patient’s record.
| Type of Lesion | Frequency | Location | Total | P Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buccal Mucosa | Tongue | Gingiva | Labial Mucosa | Floor of Mouth | Palate | Sinuses | Intraosseous | Others | ||||
| Malignant | 0.103 | |||||||||||
| SCC | 519 (100) | 114 (31.5) | 93 (25.5) | 58 (15.6) | 37 (10.7) | 24 (6.6) | 19 (4.7) | 7 (1.9) | 6 (1.6) | 9 (1.9) | 367 (100) | |
| Verrucous carcinoma | 57 (10.6) | 17 (40.5) | 4 (9.5) | 10 (23.8) | 7 (16.7) | 3 (7.1) | 1 (2.4) | 0 | 0 | 0 | 42 (11.6) | |
| Basal cell carcinoma | 7 (1.3) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 (1.6) | 6 (1.6) | |
| Spindle cell carcinoma | 3 (0.6) | 0 | 0 | 2 (100) | 0 | 0 | 0 | 0 | 0 | 0 | 2 (0.5) | |
| Clear cell carcinoma | 4 (0.7) | 1 (25) | 0 | 2 (50) | 0 | 0 | 0 | 0 | 1 (25) | 0 | 4 (1.1) | |
| Melanoma | 3 (0.6) | 0 | 0 | 1 (33) | 0 | 0 | 2 (6.7) | 0 | 0 | 0 | 3 (0.6) | |
| Premalignan | 547 (100) | 274 (57.2) | 103 (21.5) | 28 (5.8) | 47 (9.8) | 17 (3.5) | 7 (1.5) | 1 (0.2) | 0 | 1 (0.2) | 479 (100) | < 0.001 |
| Lichen planus | 408 (74.6) | 228 (62.98) | 69 (19.06) | 20 (5.52) | 35 (9.66) | 4 (1.10) | 4 (1.10) | 0 | 0 | 1 (0.2) | 362 (75.6) | |
| Leukoplakia | 115 (21) | 40 (41.7) | 27 (28.1) | 7 (7.3) | 10 (10.4) | 10 (10.4) | 2 (2.1) | 0 | 0 | 0 | 96 (20) | |
| Epithelial dysplasia | 22 (4) | 6 (31.6) | 7 (36.8) | 1 (5.3) | 2 (10.5) | 2 (10.5) | 0 | 1 (5.3) | 0 | 0 | 19 (4) | |
| Erytroplakia | 2 (0.4) | 0 | 0 | 0 | 0 | 1 (50) | 1 (50) | 0 | 0 | 0 | 2 (0.4) | |
aValues are expressed as No. (%).
bIn 220 cases, location of the lesions was not recorded in the patient’s record.